Van Den Berg Management I Holding in Unit (UNT) Cut by $1.10 Million as Stock Value Declined; As Abbott Laboratories (ABT) Share Value Declined, Beaumont Financial Partners Decreased Its Position

February 15, 2018 - By Adrian Mccoy

Van Den Berg Management I Inc decreased its stake in Unit Corp (UNT) by 3.55% based on its latest 2017Q3 regulatory filing with the SEC. Van Den Berg Management I Inc sold 54,947 shares as the company’s stock declined 20.81% while stock markets rallied. The institutional investor held 1.49 million shares of the oil & gas production company at the end of 2017Q3, valued at $30.74 million, down from 1.55 million at the end of the previous reported quarter. Van Den Berg Management I Inc who had been investing in Unit Corp for a number of months, seems to be less bullish one the $1.07 billion market cap company. The stock decreased 1.79% or $0.37 during the last trading session, reaching $20.26. About 214,917 shares traded. Unit Corporation (NYSE:UNT) has risen 62.42% since February 15, 2017 and is uptrending. It has outperformed by 45.72% the S&P500.

Beaumont Financial Partners Llc decreased its stake in Abbott Laboratories (ABT) by 9.44% based on its latest 2017Q3 regulatory filing with the SEC. Beaumont Financial Partners Llc sold 12,374 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 118,764 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.34 million, down from 131,138 at the end of the previous reported quarter. Beaumont Financial Partners Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $103.10 billion market cap company. The stock increased 1.64% or $0.96 during the last trading session, reaching $59.24. About 2.10 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 15, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, October 9 by RBC Capital Markets. As per Monday, October 2, the company rating was maintained by RBC Capital Markets. Jefferies maintained it with “Buy” rating and $65.0 target in Wednesday, October 18 report. The firm earned “Buy” rating on Wednesday, January 24 by Jefferies. Jefferies maintained Abbott Laboratories (NYSE:ABT) on Tuesday, September 5 with “Buy” rating. The firm has “Buy” rating by RBC Capital Markets given on Friday, September 1. The rating was maintained by Argus Research with “Buy” on Friday, July 21. Jefferies maintained the stock with “Buy” rating in Thursday, July 14 report. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, January 24 report. Barclays Capital maintained the shares of ABT in report on Thursday, January 25 with “Overweight” rating.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It dropped, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Honeywell International owns 523,596 shares. Wellington Gp Ltd Liability Partnership reported 0.63% stake. Bell National Bank & Trust reported 15,034 shares. Alesco Advsr Limited Liability Corp holds 4,599 shares. Gillespie Robinson & Grimm invested in 8,624 shares or 0.06% of the stock. Loeb Partners Corporation invested in 28,700 shares or 0.47% of the stock. Great West Life Assurance Can holds 0.27% or 2.04M shares. Messner And Smith Theme Value Ca stated it has 0.92% of its portfolio in Abbott Laboratories (NYSE:ABT). And Mngmt invested 0.03% in Abbott Laboratories (NYSE:ABT). Security Natl Tru invested 0.52% in Abbott Laboratories (NYSE:ABT). Moreover, Cornerstone has 2.96% invested in Abbott Laboratories (NYSE:ABT) for 317,339 shares. Fcm Invests Tx invested in 600 shares or 0.04% of the stock. Foyston Gordon And Payne holds 0.12% of its portfolio in Abbott Laboratories (NYSE:ABT) for 12,843 shares. Chesley Taft & Associates Ltd Liability Corp invested in 1.6% or 345,954 shares. Moreover, Emerald Advisers Pa has 0.04% invested in Abbott Laboratories (NYSE:ABT).

Since August 16, 2017, it had 0 insider buys, and 7 sales for $31.71 million activity. 62,460 shares valued at $3.31 million were sold by Salvadori Daniel Gesua Sive on Tuesday, September 26. Blaser Brian J also sold $1.73 million worth of Abbott Laboratories (NYSE:ABT) shares. $2.69M worth of Abbott Laboratories (NYSE:ABT) was sold by Ford Robert B. 227,412 shares were sold by Fussell Stephen R, worth $14.27M on Tuesday, January 30.

Beaumont Financial Partners Llc, which manages about $2.17 billion and $801.28M US Long portfolio, upped its stake in Fidelity (FSTA) by 51,467 shares to 639,384 shares, valued at $20.72M in 2017Q3, according to the filing. It also increased its holding in Fidelity (FUTY) by 25,120 shares in the quarter, for a total of 602,239 shares, and has risen its stake in Ishares Tr (IYW).

Investors sentiment increased to 1.15 in 2017 Q3. Its up 0.11, from 1.04 in 2017Q2. It increased, as 11 investors sold UNT shares while 51 reduced holdings. 21 funds opened positions while 50 raised stakes. 49.30 million shares or 2.78% more from 47.97 million shares in 2017Q2 were reported. Systematic Mngmt Lp holds 0.04% or 90,240 shares. 436,069 are held by Geode Capital Ltd. Ameritas Invest holds 0% of its portfolio in Unit Corporation (NYSE:UNT) for 4,371 shares. The Texas-based Texas Permanent School Fund has invested 0.01% in Unit Corporation (NYSE:UNT). Dimensional Fund Advsrs LP holds 0.04% in Unit Corporation (NYSE:UNT) or 3.91 million shares. Guinness Atkinson Asset Management holds 0.39% in Unit Corporation (NYSE:UNT) or 30,297 shares. Quantbot Limited Partnership has 10,180 shares for 0.02% of their portfolio. Mariner Wealth Advsrs Ltd Liability Com has 14,674 shares for 0.01% of their portfolio. Credit Suisse Ag owns 87,197 shares. Invesco reported 0% of its portfolio in Unit Corporation (NYSE:UNT). Federated Invsts Inc Pa, Pennsylvania-based fund reported 40,320 shares. Aperio Gru Limited Liability Com owns 38,673 shares. 938 were accumulated by Smith Asset Gp Limited Partnership. Old Mutual Customised Solutions (Proprietary) accumulated 1,400 shares. Kbc Grp Nv owns 96,221 shares for 0.02% of their portfolio.

Van Den Berg Management I Inc, which manages about $2.04B and $888.49 million US Long portfolio, upped its stake in Schlumberger Ltd (NYSE:SLB) by 79,850 shares to 367,452 shares, valued at $25.63M in 2017Q3, according to the filing. It also increased its holding in Powell Inds Inc (NASDAQ:POWL) by 85,495 shares in the quarter, for a total of 174,830 shares, and has risen its stake in Atkore Intl Group Inc.

Among 7 analysts covering Unit (NYSE:UNT), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Unit had 20 analyst reports since August 17, 2015 according to SRatingsIntel. The stock of Unit Corporation (NYSE:UNT) has “Strong Buy” rating given on Friday, May 6 by Raymond James. The firm has “Hold” rating by KLR Group given on Tuesday, October 17. The stock of Unit Corporation (NYSE:UNT) earned “Hold” rating by Cowen & Co on Thursday, January 18. On Friday, September 15 the stock rating was maintained by Cowen & Co with “Hold”. The rating was downgraded by KLR Group to “Hold” on Monday, November 21. The rating was downgraded by KLR Group on Thursday, May 26 to “Accumulate”. The stock of Unit Corporation (NYSE:UNT) earned “Hold” rating by Cowen & Co on Tuesday, July 18. As per Friday, June 24, the company rating was reinitiated by Seaport Global. The stock has “Hold” rating by Cowen & Co on Thursday, October 19. The stock of Unit Corporation (NYSE:UNT) earned “Outperform” rating by Iberia Capital Partners on Monday, August 17.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.